GLENMARK PHARMACEUTICALS LTD. - Corporate Action-Board to consider Dividend

The Board has recommended dividend @ 250% i.e. Rs. 2.5/- per share (face value of Re. 1/-) on the equity shares of the Company for FY 2023-24, subject to approval of the shareholders at the ensuing Annual General Meeting.